Bjelovar, Croatia

Ernest Mestrovic

USPTO Granted Patents = 2 

Average Co-Inventor Count = 12.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2005-2009

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Ernest Mestrovic: Innovator in Pharmaceutical Chemistry

Introduction

Ernest Mestrovic is a notable inventor based in Bjelovar, Croatia. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for medical applications. With a total of 2 patents, his work focuses on improving treatments for bacterial and protozoan infections.

Latest Patents

Mestrovic's latest patents include "Isostructural pseudopolymorphs of 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin A." This patent describes substantially pure isostructural pseudopolymorphs characterized by specific crystal parameters and their use in pharmaceutical compositions. Another significant patent is for "Amorphous 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin A," which outlines a process for preparing this compound and its applications in treating infections and inflammation-related diseases.

Career Highlights

Throughout his career, Mestrovic has worked with prominent companies in the pharmaceutical industry, including Pliva Pharmaceutical Industry, Incorporated and Pliva Hrvatska D.o.o. His expertise in pharmaceutical chemistry has allowed him to contribute to the development of innovative treatments that address critical health issues.

Collaborations

Mestrovic has collaborated with notable professionals in his field, including Marina Oresic and Aleksandar Danilovski. These collaborations have further enhanced his research and development efforts in pharmaceutical innovations.

Conclusion

Ernest Mestrovic's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an innovator in the field. His work continues to impact the development of effective treatments for various medical conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…